Yunzeng Zou Selected Research

Yunzeng Zou Research Topics

Disease

47	Cardiomegaly (Heart Hypertrophy) 12/2023 - 01/2002
39	Myocardial Infarction 01/2023 - 08/2003
33	Heart Failure 01/2022 - 12/2003
28	Fibrosis (Cirrhosis) 02/2024 - 01/2002
27	Atherosclerosis 05/2024 - 01/2004
21	Inflammation (Inflammations) 10/2023 - 12/2006
20	Hypertrophy 01/2022 - 05/2003
17	Infarction (Infarctions) 07/2021 - 08/2003
15	Hypoxia (Hypoxemia) 05/2024 - 02/2011
13	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2023 - 05/2011
13	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2004
11	Ischemia 11/2023 - 06/2012
11	Myocarditis (Carditis) 01/2022 - 02/2005
9	Reperfusion Injury 01/2023 - 12/2003
9	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 03/2011
9	Ventricular Remodeling 01/2022 - 08/2003
8	Infections 01/2022 - 01/2014
8	Hypertension (High Blood Pressure) 10/2019 - 12/2010
7	Cardiomyopathies (Cardiomyopathy) 11/2023 - 07/2002
6	Cardiotoxicity 10/2023 - 07/2002
6	Necrosis 01/2022 - 04/2012
5	Heart Diseases (Heart Disease) 01/2021 - 12/2003
4	Atherosclerotic Plaque (Atheroma) 05/2024 - 09/2015
4	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2022 - 11/2012
4	Diabetes Mellitus 10/2019 - 01/2004
4	Neointima 01/2019 - 12/2006
4	Coronary Disease (Coronary Heart Disease) 01/2019 - 06/2009
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 08/2008
4	Neoplasms (Cancer) 01/2017 - 02/2002
3	Carcinogenesis 01/2021 - 04/2014
3	Hyperlipidemias (Hyperlipidemia) 01/2020 - 11/2012
3	ST Elevation Myocardial Infarction 01/2020 - 05/2015
3	Wounds and Injuries (Trauma) 11/2017 - 09/2014

Drug/Important Bio-Agent (IBA)

24	Angiotensin IIIBA 01/2022 - 07/2002
23	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2002
9	CollagenIBA 01/2022 - 11/2006
8	Apolipoproteins E (ApoE)IBA 05/2024 - 11/2012
8	oxidized low density lipoproteinIBA 01/2022 - 05/2010
8	Type 1 Angiotensin ReceptorIBA 08/2015 - 07/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 07/2002
7	CytokinesIBA 04/2023 - 05/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
7	CalcineurinIBA 03/2014 - 01/2002
6	LipidsIBA 05/2024 - 08/2008
6	Histamine (Histamine Dihydrochloride)FDA Link 10/2023 - 08/2015
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2013
6	Aldehyde DehydrogenaseIBA 01/2019 - 01/2013
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2018 - 05/2004
5	Protein Kinases (Protein Kinase)IBA 01/2022 - 02/2002
5	Low Density Lipoprotein Receptor-Related Protein-6IBA 01/2022 - 01/2018
5	HMGB1 Protein (HMG1)IBA 01/2022 - 03/2016
5	Therapeutic UsesIBA 01/2022 - 12/2012
5	MicroRNAs (MicroRNA)IBA 08/2021 - 11/2012
5	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 06/2010
5	Mitochondrial Aldehyde DehydrogenaseIBA 08/2018 - 09/2014
5	LigandsIBA 07/2018 - 01/2004
5	Heat Shock Transcription FactorsIBA 01/2018 - 12/2003
5	Atrial Natriuretic Factor (ANF)IBA 01/2018 - 01/2002
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 04/2014
4	CalpainIBA 01/2022 - 01/2014
4	InflammasomesIBA 01/2022 - 01/2017
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2011
4	CateninsIBA 12/2021 - 12/2016
4	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2011
4	Phosphotransferases (Kinase)IBA 07/2021 - 07/2002
4	Lipoproteins (Lipoprotein)IBA 01/2016 - 11/2009
4	AngiotensinogenIBA 01/2016 - 01/2006
4	olmesartanIBA 01/2016 - 12/2010
3	Dynamins (Dynamin)IBA 11/2023 - 01/2017
3	LipopolysaccharidesIBA 10/2023 - 03/2015
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2018
3	Caspase 3 (Caspase-3)IBA 01/2022 - 07/2014
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2006
3	angiogeninIBA 01/2022 - 11/2014
3	Interleukin-17 (Interleukin 17)IBA 11/2021 - 04/2012
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 06/2004
3	InterleukinsIBA 01/2021 - 04/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2013
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 11/2012
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2019 - 12/2003
3	CholesterolIBA 01/2019 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2006
3	AntioxidantsIBA 08/2018 - 12/2011
3	urotensin IIIBA 01/2018 - 05/2011
3	naoxintongIBA 01/2018 - 01/2013
3	AldehydesIBA 10/2017 - 04/2014
3	candesartanIBA 01/2016 - 01/2006
3	HDL LipoproteinsIBA 08/2015 - 01/2011
3	qiliqiangxinIBA 06/2015 - 03/2012
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2014 - 01/2012
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2014 - 02/2008
2	p38 Mitogen-Activated Protein KinasesIBA 05/2024 - 02/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 12/2003

Therapy/Procedure

15	Therapeutics 01/2021 - 07/2002
11	Transplantation 10/2023 - 11/2006
8	Ligation 01/2020 - 01/2010
6	Percutaneous Coronary Intervention 01/2020 - 05/2015
5	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2017 - 04/2008
3	Cell Transplantation 05/2015 - 06/2010